The associations of BRCA1/2 PVs with the risks of male breast and pancreatic cancers were confirmed and refined, as well as the association of prostate cancer with BRCA2 PVs, regardless of age and aggressiveness. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.